Results 31 to 40 of about 2,408 (188)

Preservation of Olfaction after Unilateral Endoscopic Approach for Resection of Esthesioneuroblastoma

open access: yesJournal of Neurological Surgery Reports, 2014
Objectives We present a case of olfactory preservation after a unilateral transcribriform transethmoidal endoscopic resection of esthesioneuroblastoma.
Aaron Wessell   +2 more
doaj   +1 more source

Treatment Strategies and Outcomes of Pediatric Esthesioneuroblastoma: A Systematic Review

open access: yesFrontiers in Oncology, 2020
Introduction: Esthesioneuroblastoma, also known as olfactory neuroblastoma, is a small round blue cell tumor of nasal neuroepithelium first described in 1924.
Chetan Safi   +7 more
doaj   +1 more source

Craniofacial resection due to esthesioneuroblastoma: A case report

open access: yesTurkish Archives of Otorhinolaryngology, 2011
Esthesioneuroblastoma is a rare, malignant tumor originating from the olfactory neuroepithelium in the nasal cavity. This tumor has been called olfactory neuroblastoma, olfactory esthesioneuroblastoma and neuroendocrine carcinoma in the literatüre ...
Muhlis Bal   +5 more
doaj   +1 more source

Synchronous Esthesioneuroblastoma and Growth-Hormone-Secreting Pituitary Macroadenoma: Combined Open and Endoscopic Management

open access: yesJournal of Neurological Surgery Reports, 2014
Background Esthesioneuroblastoma is an uncommon malignant neoplasm that arises from the olfactory neuroepithelium. In this article we report a case of esthesioneuroblastoma presenting concomitantly with a growth-hormone (GH)-secreting pituitary ...
Costanza J. Valdes   +3 more
doaj   +1 more source

El Esthesioneuroblastoma: the impact of brain oncological disease on neuropsychological changes – Clinical Case Study

open access: yesInteracciones, 2022
Background: Esthesioneuroblastoma-type brain oncology is a rare tumor, but with extensions that can reach the base of the skull and, occasionally, can present long-distance metastases that commonly reach the lungs.
Charles Ysaacc Da Silva Rodrigues
doaj   +1 more source

Sinonasal undifferentiated carcinoma and esthesioneuroblastoma recurring as nonintestinal adenocarcinoma [PDF]

open access: yes, 2013
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/97478/1/lary23746 ...
Kang, Stephen Y.   +4 more
core   +1 more source

Long-term outcomes of locally advanced and borderline resectable esthesioneuroblastoma and sinonasal tumor with neuroendocrine differentiation treated with neoadjuvant chemotherapy

open access: yesCancer Research, Statistics, and Treatment, 2020
Background: Sinonasal tumors are a rare group of neoplasms with limited data available regarding their treatment. Objectives: To estimate the 5 year outcomes and late adverse events of locally advanced sinonasal tumors treated with neoadjuvant therapy ...
Vijay M Patil   +18 more
doaj   +1 more source

DNA Methylation Profiling in Rare Sellar Tumors

open access: yesBiomedicines, 2022
The histologic diagnosis of sellar masses can be challenging, particularly in rare neoplasms and tumors without definitive biomarkers. Moreover, there is significant inter-observer variability in the histopathological diagnosis of many tumors of the CNS,
Kyla Wright   +3 more
doaj   +1 more source

Phase 1 study of sirolimus in combination with oral cyclophosphamide and topotecan in children and young adults with relapsed and refractory solid tumors. [PDF]

open access: yes, 2016
PurposeTo determine the maximum tolerated dose (MTD), toxicities, and pharmacodynamics effects of sirolimus combined with oral metronomic topotecan and cyclophosphamide in a pediatric population.Materials and methodsPatients who were 1 to 30 years of age
Allen, Shelly   +9 more
core   +1 more source

Complex Skull Base Reconstructions in Kadish D Esthesioneuroblastoma: Case Report

open access: yesJournal of Neurological Surgery Reports, 2017
Introduction Advanced Kadish stage esthesioneuroblastoma requires more extensive resections and aggressive adjuvant therapy to obtain adequate disease-free control, which can lead to higher complication rates.
Sheri K. Palejwala   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy